Biogenesis Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.90 M
- Revenue Growth -50.07%
- Profit Growth -42.93%
- Ebitda -88.01%
- Net Worth -94.22%
- Total Assets -21.69%
About Biogenesis Labs
Biogenesis Labs Private Limited (BLPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 April 2008 and has a history of 16 years and ten months. Its registered office is in Jalgaon, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.90 M.
Ojal Amale and Bhushan Wagh serve as directors at the Company.
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U40107MH2008PTC181153
- Company No.
181153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Biogenesis Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ojal Amale  | Director | 15-Apr-2008 | Current |
| Bhushan Wagh | Director | 15-Apr-2008 | Current |
Financial Performance of Biogenesis Labs.
Biogenesis Labs Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 50.07% decrease. The company also saw a substantial fall in profitability, with a 42.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 94.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biogenesis Labs?
In 2017, Biogenesis Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹6.90 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.69 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2012 | State Bank Of India | ₹6.90 M | Open |
How Many Employees Work at Biogenesis Labs?
Unlock and access historical data on people associated with Biogenesis Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biogenesis Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenesis Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.